MedPath

Measuring the Volumes of Hypertrophic Scars and Keloids, Two Specific Kind of Scars, Over Different Points in Time in Patients Who Have Undergone Surgery and Evaluate 3D-cameras As a Possible Measuring and Documenting Tool Including Volumetry

Recruiting
Conditions
Scars, Hypertrophic
Scar Keloid
Keloid Scar Following Surgery
Registration Number
NCT06806735
Lead Sponsor
University of Zurich
Brief Summary

Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.

Detailed Description

The objective of this study is to utilize a 3D camera to measure the volumes of hypertrophic scars and keloids in patients at specified time points. The time points for measurement include day 0, as well as 3, 6, and 12 months. The 3D camera will be evaluated for their efficacy in measuring and documenting the volumes of the scars. This evaluation will include volumetry, which is the measurement of the three-dimensional space occupied by an object.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.
Exclusion Criteria
  • Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
  • lack of hypertrophic scars or keloid

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MeasurabilityDay 0, Month 3, 6 and 12

The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Universitätsspital Zürich

🇨🇭

Zürich, Switzerland

Universitätsspital Zürich

🇨🇭

Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath